Overview
Jointly organised by the SingHealth Duke-NUS Cell Therapy Centre (SDCT) and Regenerative Medicine Institute of Singapore (REMEDIS), the SDCT-REMEDIS Cell Therapy Conference returns on 23 & 24 June 2022. The conference will feature talks on the latest developments on the cell-based immunotherapy and regenerative medicine by both local and overseas experts.
The conference aims to increase knowledge and awareness on the latest innovations that are being developed among local and overseas clinicians, researchers and biotechnological companies and provide an opportunity to foster collaborations with one another to further develop and contribute to the cell therapy and regenerative medicine ecosystem in Singapore.
Scan the QR code or click here to register and submit abstract. Registration is FREE.
For any enquiries, please email sd.cell.therapy@singhealth.com.sg
Jointly organised by the SingHealth Duke-NUS Cell Therapy Centre (SDCT) and Regenerative Medicine Institute of Singapore (REMEDIS), the SDCT-REMEDIS Cell Therapy Conference returns on 23 & 24 June 2022. The conference will feature talks on the latest developments on the cell-based immunotherapy and regenerative medicine by both local and overseas experts.
The conference aims to increase knowledge and awareness on the latest innovations that are being developed among local and overseas clinicians, researchers and biotechnological companies and provide an opportunity to foster collaborations with one another to further develop and contribute to the cell therapy and regenerative medicine ecosystem in Singapore.
Scan the QR code or click here to register and submit abstract. Registration is FREE.
For any enquiries, please email sd.cell.therapy@singhealth.com.sg
Event Details
Date & Time
23 - 24 Jun 2022, 11:30 am to 08:30 pmVenue
VirtualAudience
Community Partners,Healthcare ProfessionalsLanguage
EnglishCost
FreeVenue
Virtual
Get trusted health advice, offers and more.
Subscribe to our exclusive updates for healthcare professionals.
© 2025 SingHealth Group. All Rights Reserved.